Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Megestrol Acetate Versus Liraglutide Plus Megestrol Acetate in Obese Women with Endometrial Atypical Hyperplasia: a Randomized Controlled Pilot Clinical Study

NCT04683237 is registered in ClinicalTrials.gov with Xiaojun Chen as lead sponsor.

NCT NCT04683237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04683237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Megestrol Acetate Versus Liraglutide Plus Megestrol Acetate in Obese Women with Endometrial Atypical Hyperplasia: a Randomized Controlled Pilot Clinical Study
Lead sponsor
Xiaojun Chen
Phase
Phase 2/3
Overall status
Withdrawn
Start date
March 20, 2021
Completion date
November 30, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atypical endometrial hyperplasia, fertility issues, obese